ClinicalTrials.Veeva

Menu

Balance Acceptance and Commitment Therapy for Long COVID (BalanceACT)

K

King's College London

Status

Enrolling

Conditions

Long COVID
Post-COVID-19 Syndrome

Treatments

Behavioral: Balance Acceptance and Commitment Therapy

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This randomised controlled trial aims to investigate the efficacy of a psychological intervention for long COVID (LC) / post-COVID-19 syndrome (PCS) called Balance Acceptance and Commitment Therapy (Balance ACT).

The primary objective of this trial is to investigate whether Balance-ACT improves quality of life over treatment as usual (i.e., self-help leaflet) in people with PCS/LC.

Enrollment

196 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 18 or older
  2. LC/PCS diagnosis as defined by National Health Service (NHS) / National Institute for Health and Care Excellence (NICE) (i.e., symptoms that develop during or after an infection consistent with COVID-19, continue for more than 12 weeks and are not explained by an alternative diagnosis). A checklist will be used to ensure participants fulfil the diagnostic criteria as per the NICE guidelines
  3. Ability to travel to the research site for the study assessments
  4. Having registered with a General Practitioner (GP) in the United Kingdom (UK) and consent to provide their details for the study team to contact
  5. Ability to provide informed consent
  6. Ability to read and write English

Exclusion criteria

  1. Current diagnosis of an active major mental health disorder likely to interfere with participation
  2. Unstable alcohol / drug dependency
  3. Unstable complications associated with LC/PCS
  4. Past hospitalisation for COVID-19
  5. Current or recent participation in other treatment intervention studies (<4 weeks after completion)
  6. Currently receiving psychological support or psychotherapy
  7. Pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

196 participants in 2 patient groups

Balance ACT
Experimental group
Description:
Participants randomised to Balance ACT will receive 10 therapy sessions with a therapist.
Treatment:
Behavioral: Balance Acceptance and Commitment Therapy
Treatment as usual
No Intervention group
Description:
Information leaflet about PCS/LC.

Trial contacts and locations

1

Loading...

Central trial contact

Caroline Jolley, PhD; Trudie Chalder, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems